Oncology
Conference Coverage
Dual immunotherapy goes the distance in MSI-H colorectal cancer
SAN FRANCISCO – At a median follow-up of almost 20 months, combination nivolumab and ipilimumab remained highly active as first-line therapy for...
Conference Coverage
Resecting primary tumors fails to boost survival in metastatic CRC
SAN FRANCISCO – In the first randomized trial to report on this practice, median overall survival was about 2 years regardless of whether or not...
Article
PSA cancer screening: A case for shared decision-making
Whether to screen for prostate cancer using PSA testing is a difficult decision for many men. Here’s the information you need to help them make an...
Conference Coverage
Sociodemographic disadvantage confers poorer survival in young adults with CRC
SAN FRANCISCO – Patients with colorectal cancer aged 40 years or younger who lived in areas having low income and low educational attainment, or...
Conference Coverage
Blood test may advance diagnosis of GI cancers
The Circulating Cell-free Genome Atlas (CCGA) study finds that a multicancer assay using targeted methylation sequencing of plasma cell-free DNA...
FDA/CDC
FDA approves first treatment for advanced epithelioid sarcoma
Tazemetostat earns accelerated approval for the treatment of patients aged 16 years and older with metastatic or locally advanced epithelioid...
News
New nomogram better predicts bladder cancer risk
In a retrospective analysis of patients who underwent a full microhematuria evaluation, patients with bladder cancer had a higher amount of...
News
Start of myeloma therapy may be delayed for women, minorities
Timeliness of treatment should be addressed urgently because of potential effects on disease morbidity, quality of life, and survival.
News
Adult survivors of childhood cancer are experiencing fewer major cardiac events
Reduced radiation exposure is a likely contributor to the improved cardiovascular outcomes.
FDA/CDC
FDA warns of possible cancer risk with lorcaserin
Results from a clinical trial assessing the drug’s safety showed the possible risk increase.